4.6 Review

Interventional radiological therapies in colorectal hepatic metastases

Related references

Note: Only part of the references are listed.
Article Radiology, Nuclear Medicine & Medical Imaging

Yttrium-90 Radiation Segmentectomy in Oligometastatic Secondary Hepatic Malignancies

Andrew M. Chiu et al.

Summary: A retrospective study found that yttrium-90 radiation segmentectomy is a safe and effective treatment for oligo-metastatic secondary hepatic malignancies, achieving high disease control rate.

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2023)

Article Oncology

Treatment of Metastatic Colorectal Cancer: ASCO Guideline

Van K. Morris et al.

Summary: The purpose of this study is to develop treatment recommendations for patients with metastatic colorectal cancer (mCRC). An Expert Panel convened by ASCO conducted a systematic review of relevant studies and developed recommendations for clinical practice. Based on the inclusion criteria, five systematic reviews and ten randomized controlled trials were included in the analysis. The recommendations include offering doublet chemotherapy or triplet therapy to previously untreated mCRC patients who are initially unresectable, based on studies of chemotherapy combined with anti-vascular endothelial growth factor antibodies. Pembrolizumab is recommended for first-line treatment of mCRC patients with microsatellite instability-high or deficient mismatch repair tumors. Chemotherapy and anti-epidermal growth factor receptor therapy are recommended for microsatellite stable or proficient mismatch repair left-sided treatment-naive RAS wild-type mCRC, while chemotherapy and anti-vascular endothelial growth factor therapy are recommended for microsatellite stable or proficient mismatch repair RAS wild-type right-sided mCRC. Encorafenib plus cetuximab is recommended for previously treated BRAF V600E-mutant mCRC patients who have progressed after one previous line of therapy. Other recommendations are provided for patients with colorectal peritoneal metastases, liver metastases, and candidates for potentially curative resection of liver metastases. Multidisciplinary team management and shared decision making are also recommended.

JOURNAL OF CLINICAL ONCOLOGY (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Survival of Patients with Colorectal Liver Metastases after Transarterial Chemoembolization Using Irinotecan-Eluting Microspheres: A Single-Center Retrospective Analysis Comparing RECIST 1.1 and Choi Criteria

Tishan Maraj et al.

Summary: This study evaluated the factors affecting overall survival and hepatic progression-free survival in patients with colorectal liver metastases treated with transarterial chemoembolization (TACE) using irinotecan-eluting microspheres (IEMs). The use of Choi criteria for radiologic tumor response assessment was significantly correlated with improved survival, while the use of RECIST 1.1 measurements did not show such correlation. Larger preprocedural tumor burden and the presence of extrahepatic disease were adverse prognostic factors, while previous primary resection and completion of scheduled TACE treatments were favorable prognostic factors.

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2023)

Article Oncology

The Role of Stereotactic Body Radiation Therapy in the Management of Liver Metastases

Sangjune Laurence Lee et al.

Summary: The liver is a common site for metastatic spread. Stereotactic body radiation therapy (SBRT) is a non-invasive treatment technique that can effectively ablate liver tumors. SBRT delivers high-dose radiation in one to several treatments, resulting in high rates of local control. Recent studies have shown improved survival outcomes with SBRT for oligometastatic liver disease. Clinicians must consider dose constraints to surrounding organs while delivering ablative tumor dosing. Advanced radiotherapy techniques such as proton therapy and real-time MR-guided radiotherapy can further enhance the accuracy of liver SBRT delivery.

SEMINARS IN RADIATION ONCOLOGY (2023)

Review Oncology

Irreversible Electroporation for Liver Metastases from Colorectal Cancer: A Systematic Review

Harry V. M. Spiers et al.

Summary: This study provides a systematic review of irreversible electroporation (IRE) for the treatment of colorectal hepatic metastases. The findings suggest that IRE can be a safe and effective treatment option with low morbidity and mortality rates. Further research is needed to determine the role of IRE in the overall treatment approach for colorectal liver metastases.

CANCERS (2023)

Review Radiology, Nuclear Medicine & Medical Imaging

Oligometastatic Disease in the Liver: The Role of Interventional Oncology

Ather Adnan et al.

Summary: Oligometastatic disease is an intermediate stage of cancer progression and a growing area of research. This paper reviews the advancements in understanding oligometastatic disease, options for metastasis-directed therapy, the impact of liver metastasis on immunotherapy response, and the role of image-guided interventions in cancer immunotherapy.

BRITISH JOURNAL OF RADIOLOGY (2022)

Article Cardiac & Cardiovascular Systems

Improved Outcomes of Thermal Ablation for Colorectal Liver Metastases: A 10-Year Analysis from the Prospective Amsterdam CORE Registry (AmCORE)

Robbert S. Puijk et al.

Summary: Over the last decade, the efficacy of percutaneous ablations in treating colorectal liver metastases has significantly improved. Oncological outcomes seem to have reached results comparable to open ablation. Given its minimal invasive nature and shorter hospital stay, whenever possible, percutaneous procedures may be favored over an open approach.

CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2022)

Article Oncology

Yttrium-90 for colorectal liver metastasis-the promising role of radiation segmentectomy as an alternative local cure

Pouya Entezari et al.

Summary: Y90 radioembolization has shown favorable results for patients with metastatic colorectal cancer to the liver, but its efficacy in earlier-stage disease is not promising. Radiation segmentectomy, as a novel approach, is suitable for patients with unresectable hepatocellular carcinoma.

INTERNATIONAL JOURNAL OF HYPERTHERMIA (2022)

Article Oncology

Stereotactic body radiation therapy for colorectal liver metastases

Issa Mohamad et al.

Summary: This study evaluated the efficacy and toxicity of SBRT in treating colorectal liver metastases. The results showed that SBRT can provide good local control and survival rates in patients who are not candidates for resection or RFA.

INTERNATIONAL JOURNAL OF HYPERTHERMIA (2022)

Review Oncology

Microwave Ablation, Radiofrequency Ablation, Irreversible Electroporation, and Stereotactic Ablative Body Radiotherapy for Intermediate Size (3-5 cm) Unresectable Colorectal Liver Metastases: a Systematic Review and Meta-analysis

Sanne Nieuwenhuizen et al.

Summary: This systematic review and meta-analysis compared the safety and efficacy of local ablative treatments for unresectable intermediate-size colorectal liver metastases (CRLM). The results showed that focal ablative therapy is safe and can induce long-term disease control for intermediate-size CRLM. However, there is insufficient evidence to support the superiority of one technique over another.

CURRENT ONCOLOGY REPORTS (2022)

Article Oncology

Preliminary outcomes of raltitrexed eluting bead-transarterial chemoembolization using Callispheres® beads for gastrointestinal adenocarcinoma liver metastasis

Yonghua Bi et al.

Summary: This study aimed to report the preliminary outcomes of DEB-TACE using raltitrexed-eluting CB in unresectable CALM patients. The results showed that this treatment method is safe and efficient, and can be used as an alternative choice for GALM.

WORLD JOURNAL OF SURGICAL ONCOLOGY (2022)

Review Medicine, General & Internal

Combined Trans-Arterial Embolization and Ablation for the Treatment of Large (>3 cm) Liver Metastases: Review of the Literature

Eliodoro Faiella et al.

Summary: This review evaluates the clinical practice of the combined approach of embolization and ablation in patients with secondary liver lesions larger than 3 cm who are not candidates for surgery. The studies demonstrate that this treatment is safe and has positive effects on patient survival. However, further prospective and multicentric studies are needed to evaluate its efficacy.

JOURNAL OF CLINICAL MEDICINE (2022)

Article Biotechnology & Applied Microbiology

Multimodal imaging of nano-assembled microspheres loaded with doxorubicin and Cisplatin for liver tumor therapy

Yiwei He et al.

Summary: In this study, nano-assembled microspheres (NAMs) capable of multimodal imaging and loading drugs with different charges were designed. They showed good imaging ability, drug loading, and biological safety, indicating great potential for transarterial chemoembolization (TACE) treatment of liver tumors.

FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2022)

Review Biochemistry & Molecular Biology

Relationship between Epithelial-to-Mesenchymal Transition and Tumor-Associated Macrophages in Colorectal Liver Metastases

Aurora Gazzillo et al.

Summary: The liver is the most common site for colorectal cancer (CRC) metastasis, with colorectal liver metastasis (CLM) having a poor prognosis. Tumor-associated macrophages (TAMs) play a role in promoting epithelial-to-mesenchymal transition (EMT) through the TGF-beta signaling pathway, contributing to CLM development. However, the exact mechanism of the interaction between TAMs and EMT is still poorly understood.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Radiology, Nuclear Medicine & Medical Imaging

A prospective randomized trial comparing microwave and radiofrequency ablation for the treatment of liver metastases using a dual ablation system - The Mira study

Thomas J. Vogl et al.

Summary: This study compared the therapeutic response and safety of microwave ablation (MWA) and radiofrequency ablation (RFA) for liver metastases. The results showed that MWA generated larger volumes of ablation, but there were no significant differences between the two groups in terms of overall survival, rate of neoplasm, or major complications.

EUROPEAN JOURNAL OF RADIOLOGY OPEN (2022)

Review Biochemistry & Molecular Biology

Colorectal liver metastasis: molecular mechanism and interventional therapy

Hui Zhou et al.

Summary: This review summarizes the mechanisms, diagnosis, and treatment of colorectal liver metastasis (CRLM), with a special focus on the tumor microenvironment and the potential of newer targeted therapies to improve patient prognosis.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)

Article Cardiac & Cardiovascular Systems

Clinical Application of Trans-Arterial Radioembolization in Hepatic Malignancies in Europe: First Results from the Prospective Multicentre Observational Study CIRSE Registry for SIR-Spheres Therapy (CIRT)

Thomas Helmberger et al.

Summary: The CIRT study analyzed 1027 patients and found that a majority of treatment intentions were palliative. Various malignant tumors had different median overall survival rates, and significant prognostic factors for survival included the presence of ascites, cirrhosis, extra-hepatic disease, patient performance status (ECOG), number of chemotherapy lines prior to TARE, and tumor burden.

CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Transarterial chemoembolization of colorectal cancer liver metastasis: improved tumor response by DSM-TACE versus conventional TACE, a prospective, randomized, single-center trial

Thomas J. Vogl et al.

Summary: The study compared the therapeutic response of lipiodol and DSM as embolization agents in TACE treatment for CRLM, finding that DSM-TACE significantly reduced tumor volume and showed better tumor response compared to cTACE. However, apparent diffusion coefficients were not significantly different between the two groups and cannot be used as a biomarker for monitoring therapeutic effect of TACE.

EUROPEAN RADIOLOGY (2021)

Review Gastroenterology & Hepatology

Associating liver partition and portal vein ligation for staged hepatectomy in the treatment of colorectal cancer liver metastases

Xu-Dong Wen et al.

Summary: Colorectal cancer is a common malignancy, with colorectal liver cancer metastasis being a main cause of mortality. Surgical resection is the most effective treatment, but only a few patients are suitable for radical resection. Since the introduction of ALPPS in 2012, it has shown favorable outcomes and is worth exploring by experienced surgeons.

WORLD JOURNAL OF GASTROINTESTINAL SURGERY (2021)

Article Oncology

Yttrium-90 radiation segmentectomy for hepatic metastases: A multi-institutional study of safety and efficacy

Siddharth A. Padia et al.

Summary: Y-90 radiation segmentectomy for hepatic metastases shows high rates of tumor control and minimal toxicity. This treatment should be considered for patients with metastatic hepatic malignancy who are not candidates for surgical resection.

JOURNAL OF SURGICAL ONCOLOGY (2021)

Review Oncology

Shifting the Immune-Suppressive to Predominant Immune-Stimulatory Radiation Effects by SBRT-PArtial Tumor Irradiation Targeting HYpoxic Segment (SBRT-PATHY)

Slavisa Tubin et al.

Summary: This review introduces a novel radiation therapy technique that aims to improve treatment outcomes by exploiting immune-stimulatory effects, particularly for patients with unresectable tumors and limited treatment options. This technique has the potential to enhance patient prognosis and may open up new avenues for future research.

CANCERS (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Yttrium-90 Hepatic Radioembolization for Advanced Chemorefractory Metastatic Colorectal Cancer: Survival Outcomes Based on Right-Versus Left-Sided Primary Tumor Location

Vincent Wu et al.

Summary: Primary colon cancer location affects survival outcomes of patients with metastatic colorectal cancer after salvage hepatic radioembolization with Y-90 resin microspheres. Right-sided primary tumors are independently associated with decreased survival among patients with chemorefractory metastatic colorectal cancer post-radioembolization, despite similar tumor response and progression-free survival compared with patients with left-sided primary tumors.

AMERICAN JOURNAL OF ROENTGENOLOGY (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Induction of Contralateral Hepatic Hypertrophy by Unilobar Yttrium-90 Transarterial Radioembolization versus Portal Vein Embolization: An Animal Study

Martin Liebl et al.

Summary: The study compared hepatic hypertrophy achieved by portal vein embolization (PVE) and unilobar transarterial radioembolization (TARE) in a swine model. PVE resulted in rapid hypertrophy within 1 month, followed by a plateau, while TARE showed comparable hypertrophy by 3-6 months. TARE-induced hypertrophy was correlated with radiation absorbed dose.

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Radiation segmentectomy of hepatic metastases with Y-90 glass microspheres

I. Kurilova et al.

Summary: This study showed that radiation segmentectomy can provide a high rate of local tumor control in selected patients with limited metastatic liver disease, but optimal dosimetry methodology requires further investigation.

ABDOMINAL RADIOLOGY (2021)

Review Medicine, General & Internal

The Role of Percutaneous Ablation in the Management of Colorectal Cancer Liver Metastatic Disease

Dimitrios K. Filippiadis et al.

Summary: Approximately 50% of colorectal cancer patients will develop metastases during the course of the disease. Local or locoregional therapies for the treatment of liver metastases are used in the management of oligometastatic colorectal liver disease, especially in nonsurgical candidates. Thermal ablation (TA) is recommended in the treatment of limited liver metastases as free-standing therapy or in combination with surgery as long as all visible disease can be eradicated.

DIAGNOSTICS (2021)

Article Cardiac & Cardiovascular Systems

Stereotactic Radiofrequency Ablation of Breast Cancer Liver Metastases: Short- and Long-Term Results with Predicting Factors for Survival

Peter Schullian et al.

Summary: Stereotactic RFA (SRFA) is a safe and minimally invasive treatment option for managing BCLMs, particularly in younger patients without advanced extrahepatic metastasis.

CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2021)

Review Oncology

Local Treatments in the Unresectable Patient with Colorectal Cancer Metastasis: A Review from the Point of View of the Medical Oncologist

Javier Torres-Jimenez et al.

Summary: Local treatments are a potential curative approach for patients with liver metastases of colorectal origin. Non-surgical local treatments can be beneficial for patients with isolated liver metastases who are not candidates for potentially curative resections. Various interventional therapies are available for these patients in routine clinical practice, with important clinical trials demonstrating the effectiveness of each therapy.

CANCERS (2021)

Article Biochemistry & Molecular Biology

CTHRC1 promotes liver metastasis by reshaping infiltrated macrophages through physical interactions with TGF-β receptors in colorectal cancer

Xue-Li Zhang et al.

Summary: CTHRC1 is an intrinsic marker of CRC metastasis that promotes CRC liver metastasis by reshaping infiltrated macrophages through TGF-beta signaling. CTHRC1 could be a potential biomarker for the early prediction of and a therapeutic target of CRC hepatic metastasis.

ONCOGENE (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Irreversible Electroporation to Treat Unresectable Colorectal Liver Metastases (COLDFIRE-2): A Phase II, Two-Center, Single-Arm Clinical Trial

Martijn R. Meijerink et al.

Summary: Irreversible electroporation is an effective and relatively safe treatment for colorectal liver metastases measuring 5.0 cm or smaller, especially when unsuitable for surgical resection or thermal ablation. The study showed a 1-year LTP-free survival rate of 68% post-IRE, with good local control and a median overall survival of 2.7 years.

RADIOLOGY (2021)

Article Surgery

Survival Outcomes After Portal Vein Embolization and Liver Resection Compared With Liver Transplant for Patients With Extensive Colorectal Cancer Liver Metastases

Svein Dueland et al.

Summary: The study compared the overall survival rates of patients with colorectal cancer and high liver metastasis tumor load who received liver transplant or PVE and liver resection, with patients who received liver transplant showing higher survival rates than those who underwent PVE and liver resection.

JAMA SURGERY (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Radioembolization versus portal vein embolization for contralateral liver lobe hypertrophy: effect of cirrhosis

Heiner Nebelung et al.

Summary: The study found that compared to PVE, TARE induces less pronounced hypertrophy of the FLR, with cirrhosis having less of a limiting factor for hypertrophy after TARE.

ABDOMINAL RADIOLOGY (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Survival Advantage of Yttrium-90 Radioembolization to Systemic Therapy in Patients with Hepatic Metastases from Colorectal Cancer in the Salvage Setting: Results of a Matched Pair Study

Zachary Haber et al.

Summary: The addition of transarterial Y-90Y radioembolization to systemic therapy in patients with hepatic metastases from colorectal cancer may improve survival in the salvage setting.

ACADEMIC RADIOLOGY (2021)

Review Oncology

Perspectives on Immunotherapy of Metastatic Colorectal Cancer

Yongjiu Dai et al.

Summary: Colorectal cancer, especially liver metastasis, remains a worldwide challenge. The emergence of immunotherapy has shown promise for mCRC patients with dMMR, but faces challenges for MSS tumors. More clinical trials are needed to further explore immunotherapy for mCRC patients, especially those with MSS.

FRONTIERS IN ONCOLOGY (2021)

Review Radiology, Nuclear Medicine & Medical Imaging

Combination of ablation and embolization for intermediate-sized liver metastases from colorectal cancer: what can we learn from treating primary liver cancer?

Matthew J. Seager et al.

Summary: Treatment of intermediate-size liver lesions with thermal ablation has limitations, and combination therapy may be more effective for hepatocellular carcinoma (HCC) of intermediate size. There are potential pathological similarities between CRLMs and intermediate size HCC, warranting further research and evaluation of combination treatment.

DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY (2021)

Review Gastroenterology & Hepatology

Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) in colorectal liver metastases: review of the literature

Danilo Coco et al.

Summary: The liver is a common site for metastasis in colorectal cancer patients, and surgical resection is the main option for longer survival. ALPPS technique has been introduced as a promising method to accelerate FLR hypertrophy, but it comes with high morbidity and mortality risks. More research is needed to validate its theoretical benefits in real survival outcomes.

CLINICAL AND EXPERIMENTAL HEPATOLOGY (2021)

Article Health Care Sciences & Services

Repeated centralized multidisciplinary team assessment of resectability, clinical behavior, and outcomes in 1086 Finnish metastatic colorectal cancer patients (RAXO): A nationwide prospective intervention study

Pia Osterlund et al.

Summary: The study found that repeated centralized MDT assessments in real-world metastatic CRC patients generate high resectability and resection rates, leading to impressive survival outcomes.

LANCET REGIONAL HEALTH-EUROPE (2021)

Article Oncology

Complications Following Irinotecan-Loaded Microsphere Chemoembolization of Colorectal Metastatic Liver Lesions Associated with Hepatic-Artery Branch Temporary Stasis

Marcin Szemitko et al.

Summary: Chemoembolization treatment using irinotecan-loaded microspheres for unresectable liver metastases in colorectal cancer has shown effectiveness. The study found that the level of temporary stasis in hepatic-artery branches may impact the severity of post-embolization syndrome and the occurrence of complications. Further research is needed to determine the most effective chemoembolization technique.

CURRENT ONCOLOGY (2021)

Article Cardiac & Cardiovascular Systems

CIRSE Standards of Practice on Thermal Ablation of Liver Tumours

Laura Crocetti et al.

CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2020)

Article Cardiac & Cardiovascular Systems

90Y-Radioembolization After Failed Portal Vein Embolization for Colorectal Liver Metastases: A Case Report

I Kurilova et al.

CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2020)

Article Oncology

Oncological outcomes and predictors of radiofrequency ablation of colorectal cancer liver metastases

Chuan-Zhuo Wang et al.

WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2020)

Article Oncology

Interventional Radiology for Colorectal Liver Metastases

Frederic Deschamps et al.

CURRENT COLORECTAL CANCER REPORTS (2020)

Article Radiology, Nuclear Medicine & Medical Imaging

Immunotherapy and the Interventional Oncologist: Challenges and Opportunities-A Society of Interventional Oncology White Paper

Joseph P. Erinjeri et al.

RADIOLOGY (2019)

Review Oncology

Percutaneous ablation techniques for renal cell carcinoma: current status and future trends

D. Filippiadis et al.

INTERNATIONAL JOURNAL OF HYPERTHERMIA (2019)

Review Medicine, General & Internal

Colorectal cancer

Evelien Dekker et al.

LANCET (2019)

Article Radiology, Nuclear Medicine & Medical Imaging

Evidence-Based Integration of Yttrium-90 Radioembolization in the Contemporary Management of Hepatic Metastases from Colorectal Cancer

David S. Wang et al.

TECHNIQUES IN VASCULAR AND INTERVENTIONAL RADIOLOGY (2019)

Article Radiology, Nuclear Medicine & Medical Imaging

Anatomic versus Metabolic Tumor Response Assessment after Radioembolization Treatment

Jennifer M. J. Jongen et al.

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2018)

Article Radiology, Nuclear Medicine & Medical Imaging

Radiation Segmentectomy versus Selective Chemoembolization in the Treatment of Early-Stage Hepatocellular Carcinoma

Derek M. Biederman et al.

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2018)

Article Radiology, Nuclear Medicine & Medical Imaging

Radiation Segmentectomy: Potential Curative Therapy for Early Hepatocellular Carcinoma

Robert J. Lewandowski et al.

RADIOLOGY (2018)

Review Oncology

Stereotactic body radiotherapy for colorectal cancer liver metastases: A systematic review

Fausto Petrelli et al.

RADIOTHERAPY AND ONCOLOGY (2018)

Article Oncology

Safety and initial efficacy of radiation segmentectomy for the treatment of hepatic metastases

Craig Meiers et al.

JOURNAL OF GASTROINTESTINAL ONCOLOGY (2018)

Article Oncology

Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial

Theo Ruers et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)

Article Oncology

Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial

Theo Ruers et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)

Review Radiology, Nuclear Medicine & Medical Imaging

Decision Making in Interventional Oncology: Intra-arterial Therapies for Metastatic Colorectal Cancer-Y90 and Chemoembolization

Alexandra H. Fairchild et al.

SEMINARS IN INTERVENTIONAL RADIOLOGY (2017)

Article Oncology

Yttrium-90 Radioembolization as Salvage Therapy for Liver Metastases From Colorectal Cancer

Sanjeeva P. Kalva et al.

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2017)

Article Oncology

Colorectal cancer statistics, 2017

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2017)

Article Radiology, Nuclear Medicine & Medical Imaging

Surrogate Imaging Biomarkers of Response of Colorectal Liver Metastases After Salvage Radioembolization Using 90Y-Loaded Resin Microspheres

Waleed Shady et al.

AMERICAN JOURNAL OF ROENTGENOLOGY (2016)

Review Radiology, Nuclear Medicine & Medical Imaging

Current strategies in interventional oncology of colorectal liver metastases

Tatjana Gruber-Rouh et al.

BRITISH JOURNAL OF RADIOLOGY (2016)

Article Surgery

Combined resection and RFA in colorectal liver metastases: stratification of long-term outcomes

Kazunari Sasaki et al.

JOURNAL OF SURGICAL RESEARCH (2016)

Article Multidisciplinary Sciences

Patterns of metastasis in colon and rectal cancer

Matias Riihimaki et al.

SCIENTIFIC REPORTS (2016)

Article Oncology

Ablative and Catheter-Directed Therapies for Colorectal Liver and Lung Metastases

Elena N. Petre et al.

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2015)

Article Gastroenterology & Hepatology

Local Recurrence after Radiofrequency Ablation of Hepatocellular Carcinoma: Treatment Choice and Outcome

Xiaoyan Xie et al.

JOURNAL OF GASTROINTESTINAL SURGERY (2015)

Article Radiology, Nuclear Medicine & Medical Imaging

KRAS Status as an Independent Prognostic Factor for Survival after Yttrium-90 Radioembolization Therapy for Unresectable Colorectal Cancer Liver Metastases

Steven J. Lahti et al.

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2015)

Article Gastroenterology & Hepatology

Colorectal cancer: Metastases to a single organ

Sina Vatandoust et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2015)

Review Oncology

Portal vein embolization effect on colorectal cancer liver metastasis progression: Lessons learned

Eman Al-Sharif et al.

WORLD JOURNAL OF CLINICAL ONCOLOGY (2015)

Article Radiology, Nuclear Medicine & Medical Imaging

Ablation of colorectal liver metastases by irreversible electroporation: results of the COLDFIRE-I ablate-and-resect study

H. J. Scheffer et al.

EUROPEAN RADIOLOGY (2014)

Article Radiology, Nuclear Medicine & Medical Imaging

Superselective Yttrium-90 Radioembolization for Hepatocellular Carcinoma Yields High Response Rates with Minimal Toxicity

Siddharth A. Padia et al.

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2014)

Review Oncology

Yttrium-90 radioembolization of hepatic metastases from colorectal cancer

Mihir Raval et al.

FRONTIERS IN ONCOLOGY (2014)

Article Cardiac & Cardiovascular Systems

Margin Size is an Independent Predictor of Local Tumor Progression After Ablation of Colon Cancer Liver Metastases

Xiaodong Wang et al.

CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2013)

Article Radiology, Nuclear Medicine & Medical Imaging

Microwave ablation of liver metastases to overcome the limitations of radiofrequency ablation

Anna Maria Ierardi et al.

RADIOLOGIA MEDICA (2013)

Review Radiology, Nuclear Medicine & Medical Imaging

Interventional Oncologic Approaches to Liver Metastases

Andreas H. Mahnken et al.

RADIOLOGY (2013)

Article Surgery

Tumor Progression After Preoperative Portal Vein Embolization

Lisette T. Hoekstra et al.

ANNALS OF SURGERY (2012)

Article Radiology, Nuclear Medicine & Medical Imaging

The role of early 18F-FDG PET/CT in prediction of progression-free survival after 90Y radioembolization: comparison with RECIST and tumour density criteria

I. Zerizer et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)

Article Radiology, Nuclear Medicine & Medical Imaging

Long-term results of radiofrequency ablation for unresectable colorectal liver metastases: a potentially curative intervention

A. A. J. M. van Tilborg et al.

BRITISH JOURNAL OF RADIOLOGY (2011)

Review Gastroenterology & Hepatology

Ablative therapies for colorectal liver metastases: a systematic review

S. Pathak et al.

COLORECTAL DISEASE (2011)

Article Radiology, Nuclear Medicine & Medical Imaging

Hepatic Transcatheter Arterial Chemoembolization Complicated by Postembolization Syndrome

Sabeen Dhand et al.

SEMINARS IN INTERVENTIONAL RADIOLOGY (2011)

Article Surgery

Comparative analysis of radiofrequency ablation and surgical resection for colorectal liver metastases

Kyung Ho Kim et al.

JOURNAL OF THE KOREAN SURGICAL SOCIETY (2011)

Article Radiology, Nuclear Medicine & Medical Imaging

Survival Outcomes of a Salvage Patient Population after Radioembolization of Hepatic Metastases with Yttrium-90 Microspheres

Kathryn A. Evans et al.

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2010)

Article Gastroenterology & Hepatology

Chemoembolization of hepatic malignancy

Carin F. Gonsalves et al.

ABDOMINAL IMAGING (2009)

Article Oncology

Induction of Tumor Growth After Preoperative Portal Vein Embolization: Is It a Real Problem?

Wilmar de Graaf et al.

ANNALS OF SURGICAL ONCOLOGY (2009)

Article Oncology

Effect of portal vein embolisation on the growth rate of colorectal liver metastases

V. Pamecha et al.

BRITISH JOURNAL OF CANCER (2009)

Article Cardiac & Cardiovascular Systems

Selective Internal Radiation Therapy with SIR-Spheres for the Treatment of Unresectable Colorectal Hepatic Metastases

Roberto Cianni et al.

CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2009)

Review Radiology, Nuclear Medicine & Medical Imaging

Complications Following Radioembolization with Yttrium-90 Microspheres: A Comprehensive Literature Review

Ahsun Riaz et al.

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2009)

Article Radiology, Nuclear Medicine & Medical Imaging

Local tumor progression after radiofrequency ablation of liver tumors: Analysis of morphologic pattern and site of recurrence

Shiu Kong Kei et al.

AMERICAN JOURNAL OF ROENTGENOLOGY (2008)

Article Radiology, Nuclear Medicine & Medical Imaging

Five-year survival following radiofrequency ablation of small, solitary, hepatic colorectal metastases

Alice R. Gillams et al.

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2008)

Review Gastroenterology & Hepatology

Hepatic microwave ablation: a review of the histological changes following thermal damage

Gianpiero Gravante et al.

LIVER INTERNATIONAL (2008)

Article Radiology, Nuclear Medicine & Medical Imaging

Recent advances in transarterial therapy of primary and secondary liver malignancies

Sanjeeva P. Kalva et al.

RADIOGRAPHICS (2008)

Article Radiology, Nuclear Medicine & Medical Imaging

Hepatic malignancies:: Percutaneous radiofrequency ablation during percutaneous portal or hepatic vein occlusion

Thierry de Baere et al.

RADIOLOGY (2008)

Article Radiology, Nuclear Medicine & Medical Imaging

Colorectal liver metastases: regional chemotherapy via transarterial chemoembolization (TACE) and hepatic chemoperfusion: an update

Thomas J. Vogl et al.

EUROPEAN RADIOLOGY (2007)

Article Oncology

Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases:: Modern USA experience

Andrew S. Kennedy et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)

Article Oncology

Survival after hepatic resection for colorectal metastases: A 10-year experience

AC Wei et al.

ANNALS OF SURGICAL ONCOLOGY (2006)

Article Gastroenterology & Hepatology

Yttrium-90 microspheres for the treatment of hepatocellular carcinoma

JFH Geschwind et al.

GASTROENTEROLOGY (2004)

Article Radiology, Nuclear Medicine & Medical Imaging

Influence of larze peritumoral vessels on outcome of radiofrequency ablation of liver tumors

DSK Lu et al.

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2003)

Article Oncology

Analysis of radiation-induced liver disease using the Lyman NTCP model

LA Dawson et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2002)

Article Radiology, Nuclear Medicine & Medical Imaging

Essential techniques for successful radio-frequency thermal ablation of malignant hepatic tumors

H Rhim et al.

RADIOGRAPHICS (2001)